Acceleration of chromosomal instability by loss of BRCA1 expression and p53 abnormality in sporadic breast cancers

被引:21
作者
Miyoshi, Y [1 ]
Iwao, K [1 ]
Takahashi, Y [1 ]
Egawa, C [1 ]
Noguchi, S [1 ]
机构
[1] Osaka Univ, Sch Med, Dept Surg Oncol, Suita, Osaka 5650871, Japan
关键词
chromosomal instability; BRCA1; p53; breast cancer; fluorescence in situ hybridization;
D O I
10.1016/S0304-3835(00)00558-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Correlation of chromosomal instability (CIN) with BRCA1 expression and p53 abnormality was studied in sporadic breast cancers since these genes are implicated in the double strand DNA repair and mitotic checkpoint, and loss of their function is speculated to result in the accumulation of GIN. CIN values (percentage of cells with non-modal chromosomes) were determined by fluorescence in situ hybridization of chromosomes 1, 11, and 17. BRCA1 expression was studied by immunostaining, and p53 abnormality was studied by immunostaining and polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP). CIN values of BRCA1 negative/p53 normal tumors (28.9 +/- 13.8, n = 23) and those of BRCA1 positive/p53 abnormal tumors (27.0 +/- 2.3, n = 3) were not significantly different from those of BRCA1 positive/p53 normal tumors (23.8 +/- 11.5, n = 10). On the other hand, BRCA1 negative/p53 abnormal tumors (41.2 +/- 12.7, n = 23) showed a significant (P < 0.01) increase in CIN values than BRCA1 positive/p53 normal tumors. There was no significant association between CIN values and menopausal status, tumor size, histological grade, lymph node status, or estrogen receptor status. These results suggest that BRCA1 down-regulation and p53 abnormality work synergistically to induce CIN in breast cancers, and that clinico-pathological characteristics of breast cancers with high CIN still remain to be established. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:211 / 216
页数:6
相关论文
共 34 条
  • [1] Role of the human RAD51 protein in homologous recombination and double-stranded break repair
    Baumann, P
    West, SC
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1998, 23 (07) : 247 - 251
  • [2] Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer
    Beckmann, MW
    Picard, F
    An, HX
    vanRoeyen, CRC
    Dominik, SI
    Mosny, DS
    Schnurch, HG
    Bender, HG
    Niederacher, D
    [J]. BRITISH JOURNAL OF CANCER, 1996, 73 (10) : 1220 - 1226
  • [3] p53 mutation with frequent novel codons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours
    Crook, T
    Brooks, LA
    Crossland, S
    Osin, P
    Barker, KT
    Waller, J
    Philp, E
    Smith, PD
    Yulug, I
    Peto, J
    Parker, G
    Allday, MJ
    Crompton, MR
    Gusterson, BA
    [J]. ONCOGENE, 1998, 17 (13) : 1681 - 1689
  • [4] p53 mutations in BRCA1-associated familial breast cancer
    Crook, T
    Crossland, S
    Crompton, MR
    Osin, P
    Gusterson, BA
    [J]. LANCET, 1997, 350 (9078) : 638 - 639
  • [5] EASTON DF, 1995, AM J HUM GENET, V56, P265
  • [6] Eisinger F, 1996, CANCER RES, V56, P471
  • [7] TP53 ABNORMALITIES AND GENETIC INSTABILITY IN BREAST-CANCER
    EYFJORD, JE
    THORLACIUS, S
    VALGARDSDOTTIR, R
    GRETARSDOTTIR, S
    STEINARSDOTTIR, M
    ANAMTHAWATJONSSON, K
    [J]. ACTA ONCOLOGICA, 1995, 34 (05) : 663 - 667
  • [8] Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients
    Fodor, FH
    Weston, A
    Bleiweiss, IJ
    McCurdy, LD
    Walsh, MM
    Tartter, PI
    Brower, ST
    Eng, CM
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (01) : 45 - 51
  • [9] BRCA1 MUTATIONS IN PRIMARY BREAST AND OVARIAN CARCINOMAS
    FUTREAL, PA
    LIU, QY
    SHATTUCKEIDENS, D
    COCHRAN, C
    HARSHMAN, K
    TAVTIGIAN, S
    BENNETT, LM
    HAUGENSTRANO, A
    SWENSEN, J
    MIKI, Y
    EDDINGTON, K
    MCCLURE, M
    FRYE, C
    WEAVERFELDHAUS, J
    DING, W
    GHOLAMI, Z
    SODERKVIST, P
    TERRY, L
    JHANWAR, S
    BERCHUCK, A
    IGLEHART, JD
    MARKS, J
    BALLINGER, DG
    BARRETT, JC
    SKOLNICK, MH
    KAMB, A
    WISEMAN, R
    [J]. SCIENCE, 1994, 266 (5182) : 120 - 122
  • [10] Huang TS, 1996, ONCOGENE, V13, P625